Ajanta Pharma Limited (NSE:AJANTPHARM)
India · Delayed Price · Currency is INR 2,642.10
-17.70 (-0.67%)
At close: Dec 15, 2025
Ajanta Pharma Market Cap
Ajanta Pharma has a market cap or net worth of 329.97 billion as of December 15, 2025. Its market cap has decreased by -11.83% in one year.
Market Cap
329.97B
Enterprise Value
323.02B
Revenue
49.73B
Ranking
n/a
PE Ratio
33.90
Stock Price
2,642.10
Market Cap Chart
Since April 1, 2002, Ajanta Pharma's market cap has increased from 565.80M to 329.97B, an increase of 58,218.93%. That is a compound annual growth rate of 30.81%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Dec 12, 2025 | 332.18B | -9.29% |
| Dec 31, 2024 | 366.20B | 39.58% |
| Dec 29, 2023 | 262.36B | 68.96% |
| Dec 30, 2022 | 155.28B | -19.73% |
| Dec 31, 2021 | 193.46B | 36.89% |
| Dec 31, 2020 | 141.32B | 66.18% |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2015 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Sun Pharmaceutical Industries | 4.30T |
| Divi's Laboratories | 1.71T |
| Cipla | 1.23T |
| Apollo Hospitals Enterprise | 1.02T |
| Zydus Lifesciences | 934.94B |
| Mankind Pharma | 899.42B |
| Aurobindo Pharma | 694.12B |
| Alkem Laboratories | 673.27B |